1 Value Stock to Target This Week and 2 We Find Risky

via StockStory
ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness.

DVA Cover Image

Value stocks typically trade at discounts to the broader market, offering patient investors the opportunity to buy businesses when they’re out of favor. The key risk, however, is that these stocks are usually cheap for a reason, and a low valuation can reflect underlying business challenges rather than a genuine bargain.

Identifying genuine bargains from value traps is something many investors struggle with, which is why we started StockStory - to help you find the best companies. Keeping that in mind, here is one value stock offering a compelling risk-reward profile and two with little support.

Two Value Stocks to Sell:

DaVita (DVA)

Forward P/E Ratio: 11.4x

With over 2,600 dialysis centers across the United States and a presence in 13 countries, DaVita (NYSE:DVA) operates a network of dialysis centers providing treatment and care for patients with chronic kidney disease and end-stage kidney disease.

Why Does DVA Fall Short?

  1. Flat treatments over the past two years imply it may need to invest in improvements to get back on track
  2. Estimated sales growth of 1.7% for the next 12 months implies demand will slow from its two-year trend
  3. Static adjusted operating margin over the last two years shows it couldn’t become more efficient

DaVita’s stock price of $175.88 implies a valuation ratio of 11.4x forward P/E. If you’re considering DVA for your portfolio, see our FREE research report to learn more.

SS&C (SSNC)

Forward P/E Ratio: 11.2x

Founded in 1986 as a bridge between technology and financial services, SS&C Technologies (NASDAQ:SSNC) provides software and software-enabled services that help financial firms and healthcare organizations automate complex business processes.

Why Is SSNC Not Exciting?

  1. Adjusted operating margin was unchanged over the last five years, suggesting it failed to gain leverage on its fixed costs
  2. Free cash flow margin has shown no improvement over the last five years
  3. Low returns on capital reflect management’s struggle to allocate funds effectively

SS&C is trading at $83 per share, or 11.2x forward P/E. Dive into our free research report to see why there are better opportunities than SSNC.

One Value Stock to Watch:

EVERTEC (EVTC)

Forward P/E Ratio: 7.2x

Operating one of Latin America's leading PIN debit networks called ATH, EVERTEC (NYSE:EVTC) is a payment transaction processor and financial technology provider that enables merchants and financial institutions across Latin America and the Caribbean to accept and process electronic payments.

Why Do We Like EVTC?

  1. Annual revenue growth of 12.6% over the last two years beat the sector average and underscores the unique value of its offerings
  2. Industry-leading 26.1% return on equity demonstrates management’s skill in finding high-return investments

At $29.63 per share, EVERTEC trades at 7.2x forward P/E. Is now the time to initiate a position? Find out in our full research report, it’s free.

Stocks We Like Even More

ALSO WORTH WATCHING: Top 5 Momentum Stocks. The best time to own a great stock is when the market is finally noticing it. These aren’t just high-quality businesses. Something is happening with them right now. Elite fundamentals meet near-term momentum — both boxes checked at the same time.

Find out which stocks our AI platform is flagging this week. See this week’s Strong Momentum stocks — FREE. Get Our Strong Momentum Stocks for Free HERE.

Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,460% between June 2020 and June 2025) as well as under-the-radar businesses like the once-micro-cap company Kadant (+214% between June 2020 and June 2025). Find your next big winner with StockStory today.

Report this content

If you believe this article contains misleading, harmful, or spam content, please let us know.

Report this article